These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 16817979)

  • 21. CCK-4: Psychophysiological conditioning elicits features of spontaneous panic attacks.
    Hinkelmann K; Yassouridis A; Mass R; Tenge H; Kellner M; Jahn H; Wiedemann K; Wolf K
    J Psychiatr Res; 2010 Dec; 44(16):1148-53. PubMed ID: 20451215
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anxiolytic activity of atrial natriuretic peptide in patients with panic disorder.
    Ströhle A; Kellner M; Holsboer F; Wiedemann K
    Am J Psychiatry; 2001 Sep; 158(9):1514-6. PubMed ID: 11532742
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The acute antipanic and anxiolytic activity of aerobic exercise in patients with panic disorder and healthy control subjects.
    Ströhle A; Graetz B; Scheel M; Wittmann A; Feller C; Heinz A; Dimeo F
    J Psychiatr Res; 2009 Aug; 43(12):1013-7. PubMed ID: 19289240
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Benzodiazepines counteract rostral anterior cingulate cortex activation induced by cholecystokinin-tetrapeptide in humans.
    Leicht G; Mulert C; Eser D; Sämann PG; Ertl M; Laenger A; Karch S; Pogarell O; Meindl T; Czisch M; Rupprecht R
    Biol Psychiatry; 2013 Feb; 73(4):337-44. PubMed ID: 23059050
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of a metabotropic glutamate(2/3) receptor agonist (LY544344/LY354740) on panic anxiety induced by cholecystokinin tetrapeptide in healthy humans: preliminary results.
    Kellner M; Muhtz C; Stark K; Yassouridis A; Arlt J; Wiedemann K
    Psychopharmacology (Berl); 2005 Apr; 179(1):310-5. PubMed ID: 15821951
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Behavioral and endocrine response to cholecystokinin tetrapeptide in patients with posttraumatic stress disorder.
    Kellner M; Wiedemann K; Yassouridis A; Levengood R; Guo LS; Holsboer F; Yehuda R
    Biol Psychiatry; 2000 Jan; 47(2):107-11. PubMed ID: 10664826
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Replication of action of cholecystokinin tetrapeptide in panic disorder: clinical and behavioral findings.
    Bradwejn J; Koszycki D; Payeur R; Bourin M; Borthwick H
    Am J Psychiatry; 1992 Jul; 149(7):962-4. PubMed ID: 1609879
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of 5-hydroxytryptophan on cholecystokinin-4-induced panic attacks in healthy volunteers.
    Maron E; Tõru I; Vasar V; Shlik J
    J Psychopharmacol; 2004 Jun; 18(2):194-9. PubMed ID: 15260907
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neurohormonal responses to cholecystokinin tetrapeptide: a comparison of younger and older healthy subjects.
    Flint AJ; Koszycki D; Bradwejn J; Vaccarino FJ
    Psychoneuroendocrinology; 2000 Aug; 25(6):633-47. PubMed ID: 10840174
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glyoxalase-I mRNA expression and CCK-4 induced panic attacks.
    Eser D; Uhr M; Leicht G; Asmus M; Länger A; Schüle C; Baghai TC; Mulert C; Rupprecht R
    J Psychiatr Res; 2011 Jan; 45(1):60-3. PubMed ID: 20542521
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Repetitive transcranial magnetic stimulation (rTMS) in a patient suffering from comorbid depression and panic disorder following a myocardial infarction.
    Sakkas P; Psarros C; Papadimitriou GN; Theleritis CG; Soldatos CR
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jul; 30(5):960-2. PubMed ID: 16631291
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anxiety sensitivity and response to cholecystokinin tetrapeptide in healthy volunteers.
    Koszycki D; Cox BJ; Bradwejn J
    Am J Psychiatry; 1993 Dec; 150(12):1881-3. PubMed ID: 8238648
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Health-related quality of life assessment in depression after low-frequency transcranial magnetic stimulation].
    Dumas R; Boyer L; Richieri R; Guedj E; Auquier P; Lançon C
    Encephale; 2014 Feb; 40(1):74-80. PubMed ID: 24091070
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of BI 1358894 on Cholecystokinin-Tetrapeptide (CCK-4)-Induced Anxiety, Panic Symptoms, and Stress Biomarkers: A Phase I Randomized Trial in Healthy Males.
    Goettel M; Fuertig R; Mack SR; Just S; Sharma V; Wunder A; den Boer J
    CNS Drugs; 2023 Dec; 37(12):1099-1109. PubMed ID: 38019356
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical similarity and biological diversity in the response to alprazolam in patients with panic disorder and generalized anxiety disorder.
    Klein E; Zinder O; Colin V; Zilberman I; Levy N; Greenberg A; Lenox RH
    Acta Psychiatr Scand; 1995 Dec; 92(6):399-408. PubMed ID: 8837965
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Repetitive transcranial magnetic stimulation (rTMS) to treat refractory panic disorder patient: a case report.
    Machado S; Santos V; Paes F; Arias-Carrión O; Carta MG; Silva AC; Nardi AE
    CNS Neurol Disord Drug Targets; 2014; 13(6):1075-8. PubMed ID: 24923343
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Repetitive Transcranial Magnetic Stimulation (rTMS) in the treatment of panic disorder (PD) with comorbid major depression.
    Mantovani A; Lisanby SH; Pieraccini F; Ulivelli M; Castrogiovanni P; Rossi S
    J Affect Disord; 2007 Sep; 102(1-3):277-80. PubMed ID: 17215046
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional magnetic resonance imaging characterization of CCK-4-induced panic attack and subsequent anticipatory anxiety.
    Schunck T; Erb G; Mathis A; Gilles C; Namer IJ; Hode Y; Demaziere A; Luthringer R; Macher JP
    Neuroimage; 2006 Jul; 31(3):1197-208. PubMed ID: 16600640
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of tiagabine on cholecystokinin-tetrapeptide (CCK-4)-induced anxiety in healthy volunteers.
    Zwanzger P; Eser D; Padberg F; Baghai TC; Schule C; Rötzer F; Ella R; Möller HJ; Rupprecht R
    Depress Anxiety; 2003; 18(3):140-3. PubMed ID: 14625878
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of repetitive transcranial magnetic stimulation (rTMS) add on serotonin reuptake inhibitors in patients with panic disorder: a randomized, double blind sham controlled study.
    Prasko J; Záleský R; Bares M; Horácek J; Kopecek M; Novák T; Pasková B
    Neuro Endocrinol Lett; 2007 Feb; 28(1):33-8. PubMed ID: 17277734
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.